The bidirectional relationship between periodontitis and diabetes: New prospects for stem cell-derived exosomes - 13/08/23

Abstract |
Periodontitis and diabetes have a bidirectional link, making therapeutic treatment of periodontitis and diabetes challenging. Numerous factors, including microbes, inflammatory cytokines, immune cell activity, glucose levels, and metabolic disorders, contribute to the bidirectional relationship of periodontitis and diabetes. Basic periodontal treatment, medication, surgical treatment, and combined treatment are the most widely used treatments, but their efficacy are limited. Because of their capacity to support bone remodeling and tissue regeneration and restoration, reduce blood glucose levels, restore islet function, and ameliorate local and systemic inflammation, stem cell-derived exosomes have emerged as a possible therapeutic. In this review, we summarize the utilization of stem cell-derived exosomes in periodontitis and diabetes,discuss their potential mechanisms in periodontitis and diabetes bidirectional promoters. It provides some theoretical basis for using stem cell-derived exosomes to regulate the bidirectional link between periodontitis and diabetes.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Stem cells-Exos improve the function of PDLSCs in HG environment. |
• | Exosomal miRNA is a vital mediator in the treatment of periodontitis and diabetes. |
• | Stem cells-Exos regulate periodontitis and diabetes. |
Abbreviations : AGEs, ADSC-Exos, AD-MSCs, AD-MSC-Exos, BM-MSC-Exos, BM-MSC-sEVs, COVID-19, Dexos, DPSC-Exos, DFSC-sEVs, FFAs, GMSC-Exos, GLUT-4, HAL, HbA1c, hucMSC-Exos, hucMSC-sEVs, IL-1β, IL-6, iNOS, IRS-1, LPS, LDL, miRNAs, MMP, MSCs, MSC-Exos, MenSCs, MenSC-Exos, PGE2, PMNs, PDLSC-Exos, PD-L1, RANKL, ROS, RAGEs, sIL-6R, sEVs, SHED-Exos, T2DM, T1DM, TNF-α, TC, TG, VEGF, XBP1
Keywords : Exosome, Stem cell, Small extracellular vesicle, Periodontitis, Diabetes, Periodontal regeneration, Bone resorption, Insulin resistance
Plan
Vol 165
Article 115219- septembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
